This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Albert, M. A. Articles by Ridker, P. M Search for Related Content PubMed PubMed Citation Articles by Albert, M. A. Articles by Ridker, P. M Related Collections Risk Factors Epidemiology

(Circulation. 2004;110:e7-e12.)
© 2004 American Heart Association, Inc.

Clinician Update

Perspective on Selected Issues in Cardiovascular Disease Research With a Focus on Black Americans

Michelle A. Albert, MD, MPH; Jose Torres; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH

From the Center for Cardiovascular Disease Prevention and the Leducq Center for Cardiovascular Research, Divisions of Cardiovascular Diseases and of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Dr Michelle A. Albert, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St, Boston MA 02115. E-mail maalbert@partners.org

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Case Presentation: Mr A is a healthy 38-year-old black male who comes to the clinic as a self-referral after a blood pressure check during "Health Day" at his job. Mr A is concerned because "high blood pressure" runs in his family. He reveals that his 58-year-old mother recently suffered a mild stroke and also takes water pills to reduce swelling in her legs. He denies any other health problems, is a non-smoker, and takes no medications. On physical examination, his supine blood pressure is 165/85, his heart rate is 74 bpm, and his weight is 72 kg. An ECG shows normal sinus rhythm at 76 bpm and evidence of left ventricular hypertrophy. A fasting lipid profile shows a total cholesterol level of 196 mg/dL, a low-density lipoprotein cholesterol (LDL-C) level of 120 mg/dL, a high-density lipoprotein cholesterol (HDL-C) level of 50 mg/dL, a triglyceride level of 130 mg/dL, and C-reactive protein level of 3.5 mg/L. What clinical strategy would be most appropriate for Mr A? What is the available scientific evidence to support your choice(s)?

Despite advances in the diagnosis and treatment of cardiovascular disease (CVD), morbidity and mortality from CVD is higher among black Americans than among white, Hispanic, and Asian Americans.¹ Although black Americans are often considered to have less obstructive coronary heart disease than age-matched whites,^2,3 the prevalence of traditional risk factors for CVD such as hypertension, diabetes mellitus, smoking, and obesity disproportionately affects black Americans. However, the relative importance of these risk factors and others, such . . . [Full Text of this Article]

This article has been cited by other articles:

				L. Tolkin, M. Bursztyn, I. Z. Ben-Dov, N. Simanovsky, and N. Hiller Incidental renal artery calcifications: a study of 350 consecutive abdominal computed tomography scans Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2170 - 2175. [Abstract] [Full Text] [PDF]

				R. Castillo, A. Fields, G. Qureshi, L. Salciccioli, J. Kassotis, and J. M. Lazar Relationship Between Aortic Atherosclerosis and Dental Loss in an Inner-City Population Angiology, June 1, 2009; 60(3): 346 - 350. [Abstract] [PDF]

				G. M. Campos, C. Rabl, K. Mulligan, A. Posselt, S. J. Rogers, A. C. Westphalen, F. Lin, and E. Vittinghoff Factors Associated With Weight Loss After Gastric Bypass Arch Surg, September 1, 2008; 143(9): 877 - 884. [Abstract] [Full Text] [PDF]

				S. B. Wyatt, E. L. Akylbekova, M. R. Wofford, S. A. Coady, E. R. Walker, M. E. Andrew, W. J. Keahey, H. A. Taylor, and D. W. Jones Prevalence, Awareness, Treatment, and Control of Hypertension in the Jackson Heart Study Hypertension, March 1, 2008; 51(3): 650 - 656. [Abstract] [Full Text] [PDF]

				T. A. Pearson, M. A. Denke, P. E. McBride, W. P. Battisti, R. A. Gazzara, W. E. Brady, and J. Palmisano Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial Mayo Clin. Proc., September 1, 2006; 81(9): 1177 - 1185. [Abstract] [Full Text] [PDF]

				R. S. Stafford, V. Monti, C. D. Furberg, and J. Ma Long-Term and Short-Term Changes in Antihypertensive Prescribing by Office-Based Physicians in the United States Hypertension, August 1, 2006; 48(2): 213 - 218. [Abstract] [Full Text] [PDF]

				R. P. Hertz, A. N. Unger, J. A. Cornell, and E. Saunders Racial Disparities in Hypertension Prevalence, Awareness, and Management Arch Intern Med, October 10, 2005; 165(18): 2098 - 2104. [Abstract] [Full Text] [PDF]

				A. Khera, D. K. McGuire, S. A. Murphy, H. G. Stanek, S. R. Das, W. Vongpatanasin, F. H. Wians Jr, S. M. Grundy, and J. A. de Lemos Race and Gender Differences in C-Reactive Protein Levels J. Am. Coll. Cardiol., August 2, 2005; 46(3): 464 - 469. [Abstract] [Full Text] [PDF]